IDEAS home Printed from https://ideas.repec.org/a/spr/ijphth/v60y2015i1p13-21.html
   My bibliography  Save this article

Estimating diabetes prevalence in Turkey in 2025 with and without possible interventions to reduce obesity and smoking prevalence, using a modelling approach

Author

Listed:
  • Kaan Sözmen
  • Belgin Unal
  • Simon Capewell
  • Julia Critchley
  • Martin O’Flaherty

Abstract

Diabetes burden is now a significant public health challenge, and our model predicts that its burden will increase significantly over the next two decades. Tackling obesity and other diabetes risk factors needs urgent action. Copyright Swiss School of Public Health 2015

Suggested Citation

  • Kaan Sözmen & Belgin Unal & Simon Capewell & Julia Critchley & Martin O’Flaherty, 2015. "Estimating diabetes prevalence in Turkey in 2025 with and without possible interventions to reduce obesity and smoking prevalence, using a modelling approach," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 60(1), pages 13-21, January.
    • Handle: RePEc:spr:ijphth:v:60:y:2015:i:1:p:13-21
    DOI: 10.1007/s00038-014-0622-2
    as

    Download full text from publisher

    File URL: http://hdl.handle.net/10.1007/s00038-014-0622-2
    Download Restriction: Access to full text is restricted to subscribers.
    File URL: https://libkey.io/10.1007/s00038-014-0622-2?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Andrew Briggs & Mark Sculpher & Martin Buxton, 1994. "Uncertainty in the economic evaluation of health care technologies: The role of sensitivity analysis," Health Economics, John Wiley & Sons, Ltd., vol. 3(2), pages 95-104, March.
    2. Wasim Maziak & Julia Critchley & Shahaduz Zaman & Nigel Unwin & Simon Capewell & Kathleen Bennett & Belgin Unal & Abdullatif Husseini & Habiba Romdhane & Peter Phillimore, 2013. "Mediterranean studies of cardiovascular disease and hyperglycemia: analytical modeling of population socio-economic transitions (MedCHAMPS)—rationale and methods," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 58(4), pages 547-553, August.
    3. Martin Siegel & Markus Luengen & Stephanie Stock, 2013. "On age-specific variations in income-related inequalities in diabetes, hypertension and obesity," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 58(1), pages 33-41, February.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Levent Akın & Bérengère Macabéo & Zafer Caliskan & Serdar Altinel & Ilhan Satman, 2016. "Cost-Effectiveness of Increasing Influenza Vaccination Coverage in Adults with Type 2 Diabetes in Turkey," PLOS ONE, Public Library of Science, vol. 11(6), pages 1-14, June.
    2. Maznah Ismail & Abdulsamad Alsalahi & Huzwah Khaza’ai & Mustapha Umar Imam & Der Jiun Ooi & Mad Nasir Samsudin & Zulkifli Idrus & Muhammed Ha’iz Mohd Sokhini & Musheer A. Aljaberi, 2020. "Correlation of Mortality Burdens of Cerebrovascular Disease and Diabetes Mellitus with Domestic Consumption of Soya and Palm Oils," IJERPH, MDPI, vol. 17(15), pages 1-15, July.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Simon Wieser & Bruno Horisberger & Sara Schmidhauser & Claudia Eisenring & Urs Brügger & Andreas Ruckstuhl & Jürg Dietrich & Anne Mannion & Achim Elfering & Özgür Tamcan & Urs Müller, 2011. "Cost of low back pain in Switzerland in 2005," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 12(5), pages 455-467, October.
    2. Martin J. Buxton & Michael F. Drummond & Ben A. Van Hout & Richard L. Prince & Trevor A. Sheldon & Thomas Szucs & Muriel Vray, 1997. "Modelling in Ecomomic Evaluation: An Unavoidable Fact of Life," Health Economics, John Wiley & Sons, Ltd., vol. 6(3), pages 217-227, May.
    3. Isaac Corro Ramos & Maureen P. M. H. Rutten-van Mölken & Maiwenn J. Al, 2013. "The Role of Value-of-Information Analysis in a Health Care Research Priority Setting," Medical Decision Making, , vol. 33(4), pages 472-489, May.
    4. Andrew Briggs & Paul Fenn, 1998. "Confidence intervals or surfaces? Uncertainty on the cost‐effectiveness plane," Health Economics, John Wiley & Sons, Ltd., vol. 7(8), pages 723-740, December.
    5. John Hutton, 2012. "‘Health Economics’ and the evolution of economic evaluation of health technologies," Health Economics, John Wiley & Sons, Ltd., vol. 21(1), pages 13-18, January.
    6. Berger, Loïc & Bleichrodt, Han & Eeckhoudt, Louis, 2013. "Treatment decisions under ambiguity," Journal of Health Economics, Elsevier, vol. 32(3), pages 559-569.
    7. Andrew H. Briggs & Milton C. Weinstein & Elisabeth A. L. Fenwick & Jonathan Karnon & Mark J. Sculpher & A. David Paltiel, 2012. "Model Parameter Estimation and Uncertainty Analysis," Medical Decision Making, , vol. 32(5), pages 722-732, September.
    8. Charbel El Bcheraoui & Mohammed Basulaiman & Marwa Tuffaha & Farah Daoud & Margaret Robinson & Sara Jaber & Sarah Mikhitarian & Ziad Memish & Mohammad Al Saeedi & Mohammad AlMazroa & Ali Mokdad, 2014. "Status of the diabetes epidemic in the Kingdom of Saudi Arabia, 2013," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 59(6), pages 1011-1021, December.
    9. Bangzhu Zhu & Runzhi Pang & Julien Chevallier & Yi-Ming Wei & Dinh-Tri Vo, 2019. "Including intangible costs into the cost-of-illness approach: a method refinement illustrated based on the PM2.5 economic burden in China," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(4), pages 501-511, June.
    10. Mikyung Kelly Seo & Oddbjørn Straume & Lars A. Akslen & John Cairns, 2020. "HSP27 Expression as a Novel Predictive Biomarker for Bevacizumab: is it Cost Effective?," PharmacoEconomics - Open, Springer, vol. 4(3), pages 529-539, September.
    11. Benjarin Santatiwongchai & Varit Chantarastapornchit & Thomas Wilkinson & Kittiphong Thiboonboon & Waranya Rattanavipapong & Damian G Walker & Kalipso Chalkidou & Yot Teerawattananon, 2015. "Methodological Variation in Economic Evaluations Conducted in Low- and Middle-Income Countries: Information for Reference Case Development," PLOS ONE, Public Library of Science, vol. 10(5), pages 1-15, May.
    12. Faten Tlili & Francine Tinsa & Afef Skhiri & Shahaduz Zaman & Peter Phillimore & Habiba Ben Romdhane, 2015. "Living with diabetes and hypertension in Tunisia: popular perspectives on biomedical treatment," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 60(1), pages 31-37, January.
    13. Gianluca Baio & Laura Magazzini & Claudia Oglialoro & Fabio Pammolli & Massimo Riccaboni, 2005. "Medical Devices: Competitiveness and Impact on Public Health Expenditure," Working Papers CERM 05-2005, Competitività, Regole, Mercati (CERM).
    14. Hui-Ying Tsai & Yiing-Jenq Chou & Christy Pu, 2015. "Continuity of care trajectories and emergency room use among patients with diabetes," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 60(4), pages 505-513, May.
    15. K Cooper & S C Brailsford & R Davies, 2007. "Choice of modelling technique for evaluating health care interventions," Journal of the Operational Research Society, Palgrave Macmillan;The OR Society, vol. 58(2), pages 168-176, February.
    16. Matthew Franklin & James Lomas & Simon Walker & Tracey Young, 2019. "An Educational Review About Using Cost Data for the Purpose of Cost-Effectiveness Analysis," PharmacoEconomics, Springer, vol. 37(5), pages 631-643, May.
    17. Sebastian Gurtner, 2013. "An analysis of the influence of framework aspects on the study design of health economic modeling evaluations," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 14(2), pages 221-230, April.
    18. Roman Pabayo & Ichiro Kawachi & Stephen Gilman, 2015. "US State-level income inequality and risks of heart attack and coronary risk behaviors: longitudinal findings," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 60(5), pages 573-588, July.
    19. Nancy Wolff & Thomas W. Helminiak, 1996. "Nonsampling measurement error in administrative data: Implications for economic evaluations," Health Economics, John Wiley & Sons, Ltd., vol. 5(6), pages 501-512, November.
    20. Kobelt, G., 2013. "Health Economics: An Introduction to Economic Evaluation," Monographs, Office of Health Economics, number 000004.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:ijphth:v:60:y:2015:i:1:p:13-21. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.